Definitely having a slower ramp up. The Tremfya fast-track launch really cut our legs out a bit. But I think with the better insurance coverage coming into 2018 we should see a ramp up. Its really just a setup drug to have conversations with dermatologists for IDP-118 anyway.
you must be a very uneducated person to say that. You don’t use a biological that’s forecasted to do 100’s of million dollars to sell a topical fkr psoriasis. You losers are done! Your sales are flat! Your debt won’t go away! No one wants to purchase the division!
Talk about uneducated... Sales are flat? Thats great news since they were down for the last 2 years. So things are looking up? Thanks for the positive post!
The company was doomed long ago. Then they decided to bring BH to run Derm. Wow! Some due diligence Papa did there. He was obviously brought in to sell off the division. Goo luck with that.
How many NRX for Siliq? How many $1000 rx’s Have they paid out? For the cheapest biological on the market they flu d $1000 per RX for all the sales reps. Wow!